The lower incidence of hypoglycemia after the SE bolus at 180 and 300 min postprandially suggests that the SE bolus provides more balanced insulin delivery, reducing the risk of late postprandial hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.